MIT Holdings, which is based in Savannah, will provide funding support for MEVLABS in research efforts to combat infectious diseases.

MEVLABS will be responsible for field and clinical research and production of samples for regulatory review. The firm is based in Virginia.

Specific financial details of the agreement were not disclosed.

MIT distributes pharmaceuticals worldwide and operates an ambulatory care center in Savannah.